Fundraising FoxEncore Dermatology
Malvern, US · Founded 2014 · Delaware corporation · 3 known investors
Find your way into Encore Dermatology
Sign up to see every warm intro you have to Encore Dermatology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Encore Dermatology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Specialty pharmaceutical company managing prescription dermatology assets.
Founders & leadership
Investors · 3
1315 Capitallisted by 1315 CapitalPhiladelphia · $5M – $40Mvia Adele C. Oliva · board
How we know: 1315 Capital's portfolio page · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$89.6M disclosed across 4 rounds · 2015–2019
▶$32.9MraisedApr 2019 · 11 investors · Other Health CareRule 506(b)
▶$32.9MraisedApr 2019 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert MocciaExecutive Officer, Director
- Michael BrownExecutive Officer, Director
- Juliet BakkerDirector
- Scott BarryDirector
- Charles StiefelDirector
- Adele OlivaDirector
- William CrouseDirector
- Offering amount
- $41.2M
- Amount sold
- $32.9M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$34MraisedJan 2018 · 5 investors · Other Health CareRule 506(b)
▶$34MraisedJan 2018 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William CrouseDirector
- Charles StiefelDirector
- Scott BarryDirector
- Robert MocciaExecutive Officer, Director
- Michael BrownExecutive Officer, Director
- Offering amount
- $45.5M
- Amount sold
- $34M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$12MraisedMar 2016 · 9 investors · Other Health CareRule 506(b)
▶$12MraisedMar 2016 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Charles StiefelDirector
- William CrouseDirector
- Robert MocciaExecutive Officer, Director
- Michael BrownExecutive Officer, Director
- Scott BarryDirector
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$10.7MraisedMay 2015 · 13 investors · Other Health CareRule 506(b)
▶$10.7MraisedMay 2015 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert MocciaExecutive Officer, Director
- Jay K. HachigianExecutive Officer
- Offering amount
- $10.7M
- Amount sold
- $10.7M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Encore Dermatology do?
- Specialty pharmaceutical company managing prescription dermatology assets.
- Who are Encore Dermatology's investors?
- Encore Dermatology's investors include 1315 Capital, Essex Woodlands Healthcare Partners, Longitude Capital.
- How much funding has Encore Dermatology raised?
- Encore Dermatology has disclosed $89.6M raised across 4 rounds.
- Where is Encore Dermatology headquartered?
- Encore Dermatology is headquartered in Malvern, US.